Showing results (201-210 of 316) with videos related to

Sort By:
Pageof 32
Oncotarget|May 1, 2018
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancersOsamu Soma, Shingo Hatakeyama, Teppei Okamoto, et al.
International Urology and Nephrology|August 22, 2018
Can single positive core prostate cancer at biopsy be considered a low-risk disease?Hayato Yamamoto, Takuya Koie, Teppei Ookubo, et al.
European Urology Focus|March 18, 2018
The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial CarcinomaMasaki Momota, Shingo Hatakeyama, Noriko Tokui, et al.
Clinical Genitourinary Cancer|April 30, 2025
Efficacy of Neoadjuvant Hormonal Therapy for High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Study Using Propensity Score-Matched Analysis in JapanMinori Nezasa, Makoto Kawase, Satoshi Washino, et al.
BMC Urology|October 16, 2013
Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single centerShingo Hatakeyama, Takahiro Yoneyama, Itsuto Hamano, et al.
Annals of Surgical Oncology|June 10, 2021
Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical ProstatectomyYoshinori Matsuda, Shintaro Narita, Teppei Okubo, et al.
International Journal of Clinical Oncology|February 16, 2015
Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysisTakuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, et al.
International Journal of Clinical Oncology|April 29, 2014
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomyTakuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, et al.
Medical Oncology (Northwood, London, England)|November 28, 2016
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysisTakuma Narita, Takuya Koie, Teppei Ookubo, et al.
Prostate International|December 26, 2022
Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® systemTomoki Taniguchi, Koji Iinuma, Masahiro Nakano, et al.
Pageof 32